ClinicalTrials.Veeva

Menu

Mechanomyography for Predictor of Prognosis in CuTS and PND Patients

The Washington University logo

The Washington University

Status

Completed

Conditions

Peroneal Nerve Entrapment
Cubital Tunnel Syndrome

Treatments

Device: Mechanomyography (MMG)

Study type

Observational

Funder types

Other

Identifiers

NCT04322448
201905017

Details and patient eligibility

About

The study will be a non-blinded two cohort design consisting only of symptomatic patients with CuTS or compressive peroneal neuropathy or in need of peroneal nerve decompression. The first cohort will be - patients with CuTS. Evaluation of each CuTS patient will include assessment by the treating surgeon and a certified hand therapist. Patients who have clinical examination and history consistent with a diagnosis of CuTS based on subjective and functional assessment outlined below will be consented to this study. The second cohort will be patients in need PND for compressive neuropathy of peroneal nerve. PND patients will be evaluated by clinical exam and have imaging with high resolution ultrasound or MRI negative for mass lesion.

Full description

Visit 1

  • Exam and discussion with surgeon
  • Exam and testing with Occupational Hand Therapist (Standard of Care) as described above. (CuTS cohort)
  • Diagnostic studies (EMG/NCT) (Standard of Care)
  • Questionnaires - PROMIS and ODI

Visit 2

  • Standard of Care surgery
  • During surgery, the surgeon will perform an MMG immediately pre-decompression and immediately post-decompression of the nerve. This will entail placing a sensor and probe on the nerve that will be decompressed.

Visit 3 and 4 (6 week and 3 month post-op)

  • Clinical Exam by Surgeon
  • Exam and testing with Occupational Therapist (Standard of Care) as described above. (CuTS cohort)
  • Questionnaires - PROMIS and ODI

Visit 5 (6 months post-op)

  • Clinical Exam by Surgeon
  • Exam and testing with Occupational Therapist (Standard of Care) as described above. (CuTS cohort)
  • Questionnaires - PROMIS and ODI
  • Evaluation of MMG parameters

Enrollment

23 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who have a diagnosis of Cubital Tunnel Syndrome or Compressive Peroneal Nerve Neuropathy and will be undergoing a decompressive surgery.

Exclusion criteria

  • Patients under 18 years of age
  • Patients who are unable to return for follow-up evaluation.

Trial design

23 participants in 2 patient groups

Cubital Tunnel Syndrome Patients
Description:
Cubital Tunnel Syndrome patients. Patients will undergo standard of care exams and surgery. During surgery, the surgeon will apply the mechanomyography (MMG) to the targeted nerve immediately prior and post decompression. Subjects will be followed until they are 6 months postop.
Treatment:
Device: Mechanomyography (MMG)
Peroneal Nerve Decompression Patients
Description:
Patients with compressive peroneal nerve neuropathy and will undergo a Peroneal Nerve Decompression (PND). Patients will undergo standard of care exams and surgery. During surgery, the surgeon will apply the mechanomyography (MMG) to the targeted nerve immediately prior and post decompression. Subjects will be followed until they are 6 months postop.
Treatment:
Device: Mechanomyography (MMG)

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems